TNFRSF1B (TNF receptor superfamily member 1B) - Rat Genome Database

Send us a Message



 Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Search RGD Grant Resources Citing RGD About Us Contact Us
Genes Community Projects (beta) QTLs Strains Markers Genome Information Ontologies Cell Lines References Download Submit Data
OntoMate (Literature Search) JBrowse (Genome Browser) Synteny Browser (VCMap)  (beta) Variant Visualizer Multi-Ontology Enrichment (MOET) Gene-Ortholog Location Finder (GOLF) InterViewer (Protein-Protein Interactions) PhenoMiner (Quatitative Phenotypes) Gene Annotator OLGA (Gene List Generator) AllianceMine GViewer (Genome Viewer)
Aging & Age-Related Disease Cancer & Neoplastic Disease Cardiovascular Disease Coronavirus Disease Developmental Disease Diabetes Hematologic Disease Immune & Inflammatory Disease Infectious Disease Liver Disease Neurological Disease Obesity & Metabolic Syndrome Renal Disease Respiratory Disease Sensory Organ Disease
Find Models   new Genetic Models Autism Models Rat PhenoMiner (Quantitative Phenotypes) Chinchilla PhenoMiner Expected Ranges (Quantitative Phenotype) PhenoMiner Term Comparison Hybrid Rat Diversity Panel Phenotypes GERRC (Gene Editing Rat Resource Center) Phenotypes in Other Animal Models Animal Husbandry Strain Medical Records Phylogenetics Strain Availability Calendar Rats 101 Submissions Photo Archive
Pathways
Rat Community Forum Directory of Rat Laboratories Video Tutorials News RGD Publications RGD Presentations Archive Nomenclature Guidelines Resource Links Laboratory Resources Employment Resources
Gene: TNFRSF1B (TNF receptor superfamily member 1B) Homo sapiens
Analyze
Symbol: TNFRSF1B
Name: TNF receptor superfamily member 1B
RGD ID: 1298224
HGNC Page HGNC:11917
Description: Enables tumor necrosis factor binding activity and ubiquitin protein ligase binding activity. Involved in cellular response to lipopolysaccharide and positive regulation of membrane protein ectodomain proteolysis. Located in membrane raft. Implicated in several diseases, including Parkinsonism; acne; bone disease (multiple); glomerulonephritis (multiple); and lung disease (multiple). Biomarker of several diseases, including autoimmune disease of musculoskeletal system (multiple); female reproductive organ cancer (multiple); glomerulonephritis (multiple); kidney failure (multiple); and lung disease (multiple).
Type: protein-coding
RefSeq Status: REVIEWED
Previously known as: CD120b; p75; p75 TNF receptor; p75TNFR; p80 TNF-alpha receptor; soluble TNFR1B variant 1; TBPII; TNF-R-II; TNF-R2; TNF-R75; TNF-RII; TNFBR; TNFR-II; TNFR1B; TNFR2; TNFR80; tumor necrosis factor beta receptor; tumor necrosis factor binding protein 2; tumor necrosis factor receptor 2; tumor necrosis factor receptor superfamily member 1B; tumor necrosis factor receptor superfamily, member 1B; tumor necrosis factor receptor type II
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Allele / Splice: See ClinVar data
Is Marker For: QTLs:   OSTEAR17_H   BP9_H  
Candidate Gene For: SGHRL1_H BW413_H BW442_H BW396_H
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38112,166,991 - 12,209,220 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl112,166,991 - 12,209,228 (+)EnsemblGRCh38hg38GRCh38
GRCh37112,227,048 - 12,269,277 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36112,149,647 - 12,191,864 (+)NCBINCBI36Build 36hg18NCBI36
Build 34112,161,325 - 12,203,542NCBI
Celera111,340,352 - 11,382,470 (+)NCBICelera
Cytogenetic Map1p36.22NCBI
HuRef111,380,310 - 11,422,542 (+)NCBIHuRef
CHM1_1112,214,947 - 12,257,256 (+)NCBICHM1_1
T2T-CHM13v2.0111,711,114 - 11,753,352 (+)NCBIT2T-CHM13v2.0
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View
acne  (IAGP)
acquired immunodeficiency syndrome  (IEP)
Acute Experimental Pancreatitis  (ISO)
acute kidney failure  (IEP,ISO)
adult respiratory distress syndrome  (IMP,ISO)
allergic disease  (EXP)
Alzheimer's disease  (IEP)
ankylosing spondylitis  (IDA)
Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis  (IEP)
autistic disorder  (EXP)
bacterial pneumonia  (ISO)
Bone Fractures  (EXP)
brain ischemia  (EXP)
Bronchial Spasm  (IDA)
cerebral malaria  (ISO)
Charcot-Marie-Tooth disease type 2  (IAGP)
chromosome 1p36 deletion syndrome  (IAGP)
chronic obstructive pulmonary disease  (IEP)
colon carcinoma  (IEP)
congestive heart failure  (IMP)
Crohn's disease  (ISO)
cryptogenic organizing pneumonia  (IEP)
Diabetic Nephropathies  (IEP)
end stage renal disease  (IEP)
endometrial cancer  (IEP)
endometriosis  (IDA,IMP)
Experimental Arthritis  (IMP,ISO)
Experimental Diabetes Mellitus  (IMP)
extrinsic allergic alveolitis  (IEP)
Fatigue  (IEP)
Fetal Death  (IMP)
focal segmental glomerulosclerosis  (ISO)
genetic disease  (IAGP)
glomerulonephritis  (IEP,ISO)
glomerulosclerosis  (ISO)
Headache  (IMP)
Hyperalgesia  (ISO)
Hypoalbuminemia  (EXP)
IgA glomerulonephritis  (IDA,IEP)
Inflammation  (IMP)
Intervertebral Disc Displacement  (IMP)
kidney failure  (IEP)
Legionnaires' disease  (ISO)
liver cirrhosis  (EXP)
lupus nephritis  (IDA,ISO)
mycosis fungoides  (EXP)
myocardial infarction  (ISO)
Nasal Polyps  (IEP)
Neurogenic Inflammation  (ISO)
non-alcoholic fatty liver disease  (EXP)
nonprogressive cerebellar ataxia with mental retardation  (IAGP)
obesity  (EXP)
osteoporosis  (IAGP)
ovarian cancer  (IEP)
Parkinson's disease  (ISO)
Parkinsonism  (IDA)
pneumonia  (EXP,IAGP,IDA)
polymyositis  (IEP)
pre-eclampsia  (IDA)
pulmonary sarcoidosis  (IEP)
renal cell carcinoma  (IEP)
retinal detachment  (ISO)
sciatic neuropathy  (ISO)
Sciatica  (ISO)
Sezary's disease  (EXP)
silicosis  (ISO)
Spinal Cord Compression  (IMP,ISO)
Systemic Inflammatory Response Syndrome  (ISO)
systemic lupus erythematosus  (IAGP,IEP)
Transplant Rejection  (IEP)
tuberculosis  (IAGP)
type 2 diabetes mellitus  (EXP)
ureteral obstruction  (ISO)
visual epilepsy  (ISO)

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(1->4)-beta-D-glucan  (ISO)
1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane  (ISO)
1,1-dichloroethene  (ISO)
1,2-dimethylhydrazine  (ISO)
1-naphthyl isothiocyanate  (EXP)
17alpha-ethynylestradiol  (ISO)
17beta-estradiol  (EXP,ISO)
17beta-estradiol 3-benzoate  (ISO)
2,3,7,8-tetrachlorodibenzodioxine  (EXP,ISO)
2,3,7,8-Tetrachlorodibenzofuran  (ISO)
2-amino-2-deoxy-D-glucopyranose  (EXP)
2-butoxyethanol  (ISO)
3,4-methylenedioxymethamphetamine  (ISO)
4-hydroxyphenyl retinamide  (ISO)
4-tert-butylphenol  (EXP)
5-aza-2'-deoxycytidine  (EXP)
5-fluorouracil  (EXP)
6-propyl-2-thiouracil  (ISO)
aflatoxin B1  (EXP)
Aflatoxin G1  (ISO)
aldehydo-D-glucosamine  (EXP)
alfacalcidol  (EXP)
Aloe emodin  (EXP)
alpha-naphthoflavone  (EXP)
ammonium chloride  (ISO)
antirheumatic drug  (EXP)
aripiprazole  (EXP)
aristolochic acid A  (EXP)
arsane  (EXP)
arsenic atom  (EXP)
arsenite(3-)  (ISO)
arsenous acid  (EXP,ISO)
asbestos  (EXP)
bathocuproine disulfonic acid  (EXP)
benzo[a]pyrene  (EXP,ISO)
benzo[a]pyrene diol epoxide I  (EXP)
benzoates  (EXP)
beta-D-glucosamine  (EXP)
bis(2-chloroethyl) sulfide  (EXP)
bisphenol A  (ISO)
bleomycin A2  (ISO)
cadmium atom  (EXP)
cadmium dichloride  (EXP,ISO)
carbon monoxide  (EXP)
carbon nanotube  (ISO)
chloroquine  (ISO)
ciguatoxin CTX1B  (ISO)
cisplatin  (EXP,ISO)
cocaine  (ISO)
Cuprizon  (ISO)
curcumin  (EXP)
DDE  (ISO)
dextran  (ISO)
dextran sulfate  (ISO)
diarsenic trioxide  (EXP,ISO)
dichromium trioxide  (EXP)
doxorubicin  (EXP,ISO)
epoxiconazole  (ISO)
ethanol  (EXP)
fluoranthene  (ISO)
furosemide  (ISO)
Fusarenone X  (ISO)
gefitinib  (EXP)
glyphosate  (ISO)
Heliotrine  (ISO)
hopane  (EXP)
hydrogen peroxide  (EXP)
hydroquinone  (EXP,ISO)
indole-3-methanol  (ISO)
inulin  (ISO)
ionomycin  (EXP)
ketoconazole  (ISO)
lead diacetate  (EXP,ISO)
lead nitrate  (ISO)
lead(0)  (EXP)
lenalidomide  (EXP)
lipopolysaccharide  (EXP,ISO)
melatonin  (ISO)
methyl methanesulfonate  (EXP)
Mitotane  (ISO)
monosodium L-glutamate  (ISO)
mycophenolic acid  (ISO)
N-acetyl-L-cysteine  (ISO)
N-methyl-4-phenylpyridinium  (EXP)
N-nitrosodiethylamine  (ISO)
nickel atom  (EXP)
nickel sulfate  (EXP)
nitrogen dioxide  (EXP)
obeticholic acid  (EXP)
octreotide  (ISO)
oleanolic acid  (ISO)
osthole  (EXP)
oxidopamine  (EXP)
ozone  (EXP,ISO)
p-menthan-3-ol  (EXP)
paracetamol  (EXP,ISO)
paraquat  (EXP)
pentachlorophenol  (ISO)
perfluorodecanoic acid  (EXP)
perfluorononanoic acid  (EXP)
perfluorooctane-1-sulfonic acid  (ISO)
perfluoroundecanoic acid  (EXP)
phorbol 13-acetate 12-myristate  (EXP)
pioglitazone  (ISO)
pirinixic acid  (EXP,ISO)
pregnenolone 16alpha-carbonitrile  (ISO)
prenyl diphosphate  (EXP)
procyanidin B3  (ISO)
progesterone  (EXP)
pyrrolidine dithiocarbamate  (EXP)
quercetin  (EXP)
quercitrin  (EXP)
resveratrol  (ISO)
sanguinarine  (EXP)
SB 203580  (ISO)
senecionine  (ISO)
serpentine asbestos  (ISO)
simvastatin  (ISO)
sodium arsenite  (EXP,ISO)
sodium stibogluconate  (EXP)
streptozocin  (EXP,ISO)
succimer  (ISO)
sulfur dioxide  (EXP)
temozolomide  (EXP)
terameprocol  (ISO)
testosterone  (ISO)
tetrachloromethane  (ISO)
thalidomide  (EXP)
thioacetamide  (ISO)
titanium dioxide  (ISO)
trichloroethene  (ISO)
uranium atom  (EXP)
valproic acid  (EXP)
vemurafenib  (EXP)
vinclozolin  (ISO)
WR-1065  (ISO)
zoledronic acid  (EXP)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process
aortic valve development  (IEA,ISS)
apoptotic process  (IEA)
cell surface receptor signaling pathway  (IEA,ISO)
cellular response to growth factor stimulus  (IEA,ISO)
cellular response to lipopolysaccharide  (IMP)
cellular response to tumor necrosis factor  (IEA,ISO)
extrinsic apoptotic signaling pathway  (IBA,IEA,ISO)
glial cell-neuron signaling  (IEA,ISS)
immune response  (IEA,ISO)
inflammatory response  (IEA,ISO)
intrinsic apoptotic signaling pathway in response to DNA damage  (IBA,IEA,ISO)
negative regulation of cardiac muscle hypertrophy  (IEA)
negative regulation of extracellular matrix constituent secretion  (IEA,ISS)
negative regulation of inflammatory response  (IEA,ISO)
negative regulation of neuroinflammatory response  (IBA,IEA,ISS)
positive regulation of apoptotic process involved in morphogenesis  (IEA,ISS)
positive regulation of membrane protein ectodomain proteolysis  (IBA,IMP)
positive regulation of myelination  (IBA,IEA,ISS)
positive regulation of oligodendrocyte differentiation  (IBA,IEA,ISS)
programmed cell death  (ISO)
pulmonary valve development  (IEA,ISS)
regulation of cytokine production involved in immune response  (IEA,ISS)
regulation of myelination  (IEA,ISS)
regulation of neuroinflammatory response  (IEA,ISS)
regulation of T cell cytokine production  (IBA,IEA,ISS)
regulation of T cell proliferation  (IBA,IEA,ISS)
response to lipopolysaccharide  (IEA,ISO)
RNA destabilization  (IEA,ISO)
tumor necrosis factor-mediated signaling pathway  (IEA,ISO,TAS)

Cellular Component

Molecular Function

Molecular Pathway Annotations     Click to see Annotation Detail View
Phenotype Annotations     Click to see Annotation Detail View
References

References - curated
# Reference Title Reference Citation
1. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Aderka D, etal., Arthritis Rheum. 1993 Aug;36(8):1111-20.
2. Increased serum levels of soluble receptors for tumor necrosis factor in cancer patients. Aderka D, etal., Cancer Res. 1991 Oct 15;51(20):5602-7.
3. Tumor necrosis factor receptor expression and signaling in renal cell carcinoma. Al-Lamki RS, etal., Am J Pathol. 2010 Aug;177(2):943-54. doi: 10.2353/ajpath.2010.091218. Epub 2010 Jun 21.
4. The thalidomide analgesic effect is associated with differential TNF-alpha receptor expression in the dorsal horn of the spinal cord as studied in a rat model of neuropathic pain. Andrade P, etal., Brain Res. 2012 Apr 23;1450:24-32. doi: 10.1016/j.brainres.2012.02.033. Epub 2012 Feb 22.
5. Fc gamma RIIa polymorphism: a susceptibility factor for immune complex-mediated lupus nephritis in Brazilian patients. Bazilio AP, etal., Nephrol Dial Transplant. 2004 Jun;19(6):1427-31. Epub 2004 Mar 5.
6. Anti-tumor necrosis factor alpha treatment of interferon-alpha-induced murine lupus nephritis reduces the renal macrophage response but does not alter glomerular immune complex formation. Bethunaickan R, etal., Arthritis Rheum. 2012 Oct;64(10):3399-408. doi: 10.1002/art.34553.
7. Fatigue and proinflammatory cytokine activity in breast cancer survivors. Bower JE, etal., Psychosom Med. 2002 Jul-Aug;64(4):604-11.
8. TNFR2 interposes the proliferative and NF-kappaB-mediated inflammatory response by podocytes to TNF-alpha. Bruggeman LA, etal., Lab Invest. 2011 Mar;91(3):413-25. doi: 10.1038/labinvest.2010.199. Epub 2011 Jan 10.
9. The levels of nitric oxide and asymmetric dimethylarginine in the rat endometriosis model. Cayci T, etal., J Obstet Gynaecol Res. 2011 Apr 12. doi: 10.1111/j.1447-0756.2010.01482.x.
10. Expression of tumour necrosis factor receptors by bronchoalveolar cells in hypersensitivity pneumonitis. Chen B, etal., Eur Respir J. 2005 Jun;25(6):1039-43.
11. The effect of intra-articular injection of different concentrations of ozone on the level of TNF-alpha, TNF-R1, and TNF-R2 in rats with rheumatoid arthritis. Chen H, etal., Rheumatol Int. 2013 May;33(5):1223-7. doi: 10.1007/s00296-012-2529-7. Epub 2012 Oct 2.
12. Tumor Necrosis Factor-Alpha Antagonist Reduces Apoptosis of Neurons and Oligodendroglia in Rat Spinal Cord Injury. Chen KB, etal., Spine (Phila Pa 1976). 2011 Jan 8.
13. Differential activation of tumor necrosis factor receptors distinguishes between brains from Alzheimer's disease and non-demented patients. Cheng X, etal., J Alzheimers Dis. 2010;19(2):621-30. doi: 10.3233/JAD-2010-1253.
14. Ozone-induced lung inflammation and hyperreactivity are mediated via tumor necrosis factor-alpha receptors. Cho HY, etal., Am J Physiol Lung Cell Mol Physiol. 2001 Mar;280(3):L537-46.
15. Endogenous tumor necrosis factor alpha (TNFalpha) requires TNF receptor type 2 to generate heat hyperalgesia in a mouse cancer model. Constantin CE, etal., J Neurosci. 2008 May 7;28(19):5072-81.
16. Circulating levels of TNF-alpha and its soluble receptors in the plasma of patients with epithelial ovarian cancer. Dobrzycka B, etal., Eur Cytokine Netw. 2009 Sep;20(3):131-4.
17. Sources of alveolar soluble TNF receptors during acute lung injury of different etiologies. Dorr AD, etal., J Appl Physiol. 2011 Apr 21.
18. Efficacy of etanercept on rheumatic signs and pulmonary function tests in advanced ankylosing spondylitis: results of a randomised double-blind placebo-controlled study (SPINE). Dougados M, etal., Ann Rheum Dis. 2011 May;70(5):799-804. Epub 2011 Feb 13.
19. Bronchospasm associated with anti-TNF treatment. Dubey S, etal., Clin Rheumatol. 2009 Aug;28(8):989-92. Epub 2009 Apr 2.
20. Lipopolysaccharide signaling in the carotid chemoreceptor pathway of rats with sepsis syndrome. Fernandez R, etal., Respir Physiol Neurobiol. 2011 Mar 15;175(3):336-48. Epub 2010 Dec 30.
21. TNF receptor 1 and 2 contribute in different ways to resistance to Legionella pneumophila-induced mortality in mice. Fujita M, etal., Cytokine. 2008 Nov;44(2):298-303. Epub 2008 Oct 5.
22. Serum levels of soluble receptors for tumor necrosis factor (p55 and p75 sTNFr) in endometrial cancer. Gadducci A, etal., Anticancer Res. 1996 Sep-Oct;16(5B):3125-8.
23. Linkage and association of tumor necrosis factor receptor 2 locus with hypertension, hypercholesterolemia and plasma shed receptor. Glenn CL, etal., Hum Mol Genet 2000 Aug 12;9(13):1943-9.
24. GOAs Human GO annotations GOA_HUMAN data from the GO Consortium
25. Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. Gohda T, etal., J Am Soc Nephrol. 2012 Mar;23(3):516-24. doi: 10.1681/ASN.2011060628. Epub 2012 Jan 19.
26. Circulating TNF-alpha and its soluble receptors during experimental acute pancreatitis. Granell S, etal., Cytokine. 2004 Feb 21;25(4):187-91.
27. Role of TNFR1 and TNFR2 receptors in tubulointerstitial fibrosis of obstructive nephropathy. Guo G, etal., Am J Physiol. 1999 Nov;277(5 Pt 2):F766-72.
28. Early subcutaneous administration of etanercept (Enbrel) prevents from hyperoxia-induced lung injury. Guthmann F, etal., Exp Lung Res. 2009 Nov;35(9):770-80.
29. Changes in cardiac structure in hypertension produced by placental ischemia in pregnant rats: effect of tumor necrosis factor blockade. Gutkowska J, etal., J Hypertens. 2011 Apr 17.
30. Methamphetamine-induced dopamine transporter complex formation and dopaminergic deficits: the role of D2 receptor activation. Hadlock GC, etal., J Pharmacol Exp Ther. 2010 Oct;335(1):207-12. Epub 2010 Jul 9.
31. The role of TNFalpha in the periaqueductal gray during naloxone-precipitated morphine withdrawal in rats. Hao S, etal., Neuropsychopharmacology. 2011 Feb;36(3):664-76. Epub 2010 Nov 10.
32. Expression of tumor necrosis factor receptors on granulocytes in patients with myeloperoxidase anti-neutrophil cytoplasmic autoantibody-associated vasculitis. Hasegawa M, etal., Nephron Clin Pract. 2009;113(3):c222-33. doi: 10.1159/000235242. Epub 2009 Aug 18.
33. Genetic variants in inflammation-related genes are associated with radiation-induced toxicity following treatment for non-small cell lung cancer. Hildebrandt MA, etal., PLoS One. 2010 Aug 25;5(8):e12402.
34. Upregulation of TNF receptor type 2 in human and experimental renal allograft rejection. Hoffmann U, etal., Am J Transplant. 2009 Apr;9(4):675-86. doi: 10.1111/j.1600-6143.2008.02536.x. Epub 2008 Mar 2.
35. Direct application of the tumor necrosis factor-alpha inhibitor, etanercept, into a punctured intervertebral disc decreases calcitonin gene-related peptide expression in rat dorsal root ganglion neurons. Horii M, etal., Spine (Phila Pa 1976). 2011 Jan 15;36(2):E80-5.
36. Vesicular monoamine transporter 2 and dopamine transporter are molecular targets of Pitx3 in the ventral midbrain dopamine neurons. Hwang DY, etal., J Neurochem. 2009 Dec;111(5):1202-12. Epub 2009 Sep 24.
37. Elevated serum levels of the type I and type II receptors for tumor necrosis factor-alpha as predictive factors for ARF in patients with septic shock. Iglesias J, etal., Am J Kidney Dis. 2003 Jan;41(1):62-75.
38. Tumor necrosis factor alpha pathways develops liver apoptosis in type 1 diabetes mellitus. Ingaramo PI, etal., Mol Immunol. 2011 Apr 8.
39. Differences between tumor necrosis factor-alpha receptors types 1 and 2 in the modulation of spinal glial cell activation and mechanical allodynia in a rat sciatic nerve injury model. Ishikawa T, etal., Spine (Phila Pa 1976). 2013 Jan 1;38(1):11-6. doi: 10.1097/BRS.0b013e3182610fa9.
40. Regression of endometrial autografts in a rat model of endometriosis treated with etanercept. Islimye M, etal., Eur J Obstet Gynecol Reprod Biol. 2011 Nov;159(1):184-9. doi: 10.1016/j.ejogrb.2011.06.029. Epub 2011 Jul 7.
41. Elevated CSF levels of TACE activity and soluble TNF receptors in subjects with mild cognitive impairment and patients with Alzheimer's disease. Jiang H, etal., Mol Neurodegener. 2011 Oct 6;6:69. doi: 10.1186/1750-1326-6-69.
42. TNF-alpha in hypothalamic paraventricular nucleus contributes to sympathoexcitation in heart failure by modulating AT1 receptor and neurotransmitters. Kang YM, etal., Tohoku J Exp Med. 2010;222(4):251-63.
43. Serum cytokine profile in patients with active lupus nephritis. Koenig KF, etal., Cytokine. 2012 Nov;60(2):410-6. doi: 10.1016/j.cyto.2012.07.004. Epub 2012 Jul 28.
44. Roles of TNF-alpha and its receptors in the beneficial effects of vagal stimulation after myocardial infarction in rats. Kong SS, etal., Clin Exp Pharmacol Physiol. 2011 Mar 1. doi: 10.1111/j.1440-1681.2011.05505.x.
45. The association of serum lipids and inflammatory biomarkers with renal function in men with type II diabetes mellitus. Lin J, etal., Kidney Int. 2006 Jan;69(2):336-42.
46. Predictive and pathogenetic value of plasma biomarkers for acute kidney injury in patients with acute lung injury. Liu KD, etal., Crit Care Med. 2007 Dec;35(12):2755-61.
47. Inflammatory profile and response to anti-TNF therapy in patients with chronic pulmonary sarcoidosis. Loza MJ, etal., Clin Vaccine Immunol. 2011 Apr 20.
48. Treatment of experimental adjuvant arthritis with a novel folate receptor-targeted folic acid-aminopterin conjugate. Lu Y, etal., Arthritis Res Ther. 2011 Apr 4;13(2):R56.
49. Decrease in tumor necrosis factor-alpha receptor-associated death domain results from ubiquitin-dependent degradation in obstructive renal injury in rats. Misaki T, etal., Am J Pathol. 2009 Jul;175(1):74-83. doi: 10.2353/ajpath.2009.080884. Epub 2009 Jun 18.
50. A functional haplotype in the 3'untranslated region of TNFRSF1B is associated with tuberculosis in two African populations. Moller M, etal., Am J Respir Crit Care Med. 2010 Feb 15;181(4):388-93. Epub 2009 Dec 10.
51. Tumor necrosis factor-alpha mediates photoreceptor death in a rodent model of retinal detachment. Nakazawa T, etal., Invest Ophthalmol Vis Sci. 2011 Mar 14;52(3):1384-91. Print 2011 Mar.
52. Lack of soluble tumor necrosis factor alpha receptor 1 and 2 and interleukin-1beta compartmentalization in lungs of mice after a single intratracheal inoculation with live Porphyromonas gingivalis. Nemec A, etal., Exp Lung Res. 2009 Sep;35(7):605-20.
53. Serum concentrations of markers of TNFalpha and Fas-mediated pathways and renal function in nonproteinuric patients with type 1 diabetes. Niewczas MA, etal., Clin J Am Soc Nephrol. 2009 Jan;4(1):62-70. Epub 2008 Dec 10.
54. Circulating TNF receptors 1 and 2 predict ESRD in type 2 diabetes. Niewczas MA, etal., J Am Soc Nephrol. 2012 Mar;23(3):507-15. doi: 10.1681/ASN.2011060627. Epub 2012 Jan 19.
55. Mechanisms of immune complex-mediated experimental glomerulonephritis: possible role of the balance between endogenous TNF and soluble TNF receptor type 2. Pfeifer E, etal., Eur Cytokine Netw. 2012 Mar 1;23(1):15-20. doi: 10.1684/ecn.2012.0299.
56. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
57. PID Annotation Import Pipeline Pipeline to import Pathway Interaction Database annotations from NCI into RGD
58. MicroRNA Expression in Induced Sputum of Smokers and Patients with Chronic Obstructive Pulmonary Disease. Pottelberge GR, etal., Am J Respir Crit Care Med. 2011 Apr 1;183(7):898-906. Epub 2010 Oct 29.
59. TNFR2-mediated apoptosis and necrosis in cisplatin-induced acute renal failure. Ramesh G and Reeves WB, Am J Physiol Renal Physiol. 2003 Oct;285(4):F610-8. Epub 2003 Jul 15.
60. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. Renaud SJ, etal., J Immunol. 2011 Feb 1;186(3):1799-808. Epub 2010 Dec 27.
61. ClinVar Automated Import and Annotation Pipeline RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
62. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
63. Enzymatic-nonenzymatic cellular antioxidant defense systems response and immunohistochemical detection of MDMA, VMAT2, HSP70, and apoptosis as biomarkers for MDMA (Ecstasy) neurotoxicity. Riezzo I, etal., J Neurosci Res. 2010 Mar;88(4):905-16.
64. Quantification of the mRNA encoding Tumor Necrosis Factor alpha (TNFalpha) and its receptors in human nasal polyps. Rostkowska-Nadolska B, etal., Adv Med Sci. 2008;53(2):263-9.
65. Imbalances in serum proinflammatory cytokines and their soluble receptors: a putative role in the progression of idiopathic IgA nephropathy (IgAN) and Henoch-Schonlein purpura nephritis, and a potential target of immunoglobulin therapy? Rostoker G, etal., Clin Exp Immunol. 1998 Dec;114(3):468-76.
66. Plasma concentrations of TNF-alpha and its soluble receptors sTNFR1 and sTNFR2 in patients with coronary artery disease. Safranow K, etal., Tissue Antigens. 2009 Nov;74(5):386-92.
67. Etanercept restores the antinociceptive effect of morphine and suppresses spinal neuroinflammation in morphine-tolerant rats. Shen CH, etal., Anesth Analg. 2011 Feb;112(2):454-9. Epub 2010 Nov 16.
68. Moxibustion treatment restoring the intestinal epithelium barrier in rats with Crohn's disease by down-regulating tumor necrosis factor alpha, tumor necrosis factor receptor 1, and tumor necrosis factor receptor 2. Shi Y, etal., Chin J Integr Med. 2011 Mar;17(3):212-7. Epub 2011 Feb 27.
69. Elevation of serum soluble tumour necrosis factor receptors in patients with polymyositis and dermatomyositis. Shimizu T, etal., Clin Rheumatol. 2000;19(5):352-9.
70. Axonal transport of TNF-alpha in painful neuropathy: distribution of ligand tracer and TNF receptors. Shubayev VI and Myers RR, J Neuroimmunol. 2001 Mar 1;114(1-2):48-56.
71. TNF-alpha type 2 receptor mediates renal inflammatory response to chronic angiotensin II administration with high salt intake in mice. Singh P, etal., Am J Physiol Renal Physiol. 2013 Apr 1;304(7):F991-9. doi: 10.1152/ajprenal.00525.2012. Epub 2013 Feb 6.
72. Increased expression of tumor necrosis factor-alpha receptors in the brains of patients with AIDS. Sippy BD, etal., J Acquir Immune Defic Syndr Hum Retrovirol. 1995 Dec 15;10(5):511-21.
73. [Interleukin-6, tumor necrosis factor alpha and their soluble receptors in Bence-Jones nephropathy. Possible role in pathogenesis andthe importance in the determination of prognosis in renal insufficiency]. Spicka I, etal., Cas Lek Cesk. 1998 May 4;137(9):267-70.
74. Requirement for tumor necrosis factor receptor 2 expression on vascular cells to induce experimental cerebral malaria. Stoelcker B, etal., Infect Immun. 2002 Oct;70(10):5857-9.
75. Role of TNFR1 in lung injury and altered lung function induced by the model sulfur mustard vesicant, 2-chloroethyl ethyl sulfide. Sunil VR, etal., Toxicol Appl Pharmacol. 2011 Feb 1;250(3):245-55. Epub 2010 Nov 9.
76. Association study of tumor necrosis factor receptor type 2 M196R and toll-like receptor 2 Arg753Gln polymorphisms with acne vulgaris in a Chinese Han ethnic group. Tian LM, etal., Dermatology. 2010;221(3):276-84. doi: 10.1159/000319851.
77. Analysis of the association of HLA-DRB1, TNFalpha promoter and TNFR2 (TNFRSF1B) polymorphisms with SLE using transmission disequilibrium test. Tsuchiya N, etal., Genes Immun. 2001 Oct;2(6):317-22.
78. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. Vielhauer V, etal., J Clin Invest. 2005 May;115(5):1199-209. Epub 2005 Apr 1.
79. Tumor necrosis factor signaling. Wajant H, etal., Cell Death Differ. 2003 Jan;10(1):45-65.
80. Opposing actions of hippocampus TNFalpha receptors on limbic seizure susceptibility. Weinberg MS, etal., Exp Neurol. 2013 Jan 16. pii: S0014-4886(13)00024-1. doi: 10.1016/j.expneurol.2013.01.011.
81. Robust and comprehensive analysis of 20 osteoporosis candidate genes by very high-density single-nucleotide polymorphism screen among 405 white nuclear families identified significant association and gene-gene interaction. Xiong DH, etal., J Bone Miner Res. 2006 Nov;21(11):1678-95.
82. The impact of soluble tumor necrosis factor receptor etanercept on the treatment of idiopathic pneumonia syndrome after allogeneic hematopoietic stem cell transplantation. Yanik GA, etal., Blood. 2008 Oct 15;112(8):3073-81. Epub 2008 Jul 29.
83. Increased expression of tumor necrosis factor receptors in cryptogenic organizing pneumonia. Ye Q, etal., Respir Med. 2011 Feb;105(2):292-7. Epub 2010 Dec 8.
84. [Effect of intra-articular ozone injection on serum and synovial TNF-alpha, TNFR I, and TNFR II contents in rats with rheumatoid arthritis]. Yu B, etal., Nan Fang Yi Ke Da Xue Xue Bao. 2011 Jun;31(6):1055-8.
85. Tumor necrosis factor-alpha induces sensitization of meningeal nociceptors mediated via local COX and p38 MAP kinase actions. Zhang XC, etal., Pain. 2011 Jan;152(1):140-9. Epub 2010 Oct 30.
86. Neuroprotection with a brain-penetrating biologic tumor necrosis factor inhibitor. Zhou QH, etal., J Pharmacol Exp Ther. 2011 Nov;339(2):618-23. doi: 10.1124/jpet.111.185876. Epub 2011 Aug 10.
87. Predictive value of conjointly examined IL-1ra, TNF-R I, TNF-R II, and RANTES in patients with primary glomerulonephritis. Zwiech R J Korean Med Sci. 2013 Feb;28(2):261-7. doi: 10.3346/jkms.2013.28.2.261. Epub 2013 Jan 29.
88. [Prognostic values of serum concentration and urinary excretion of interleukin-1 receptor antagonist and tumor necrosis factor receptors type I and II in patients with IGA nephropathy]. Zwiech R, etal., Pol Arch Med Wewn. 2005 Apr;113(4):326-33.
Additional References at PubMed
PMID:1310388   PMID:1328224   PMID:1335762   PMID:1655619   PMID:1663076   PMID:1929203   PMID:1966549   PMID:2153136   PMID:2158863   PMID:2160731   PMID:2166946   PMID:2172983  
PMID:2173696   PMID:7539446   PMID:7544915   PMID:7559483   PMID:7639698   PMID:7664431   PMID:7821811   PMID:7852363   PMID:7859281   PMID:7884318   PMID:7930591   PMID:7966397  
PMID:8051045   PMID:8069916   PMID:8123048   PMID:8182064   PMID:8548810   PMID:8590321   PMID:8661109   PMID:8702708   PMID:8702885   PMID:8710854   PMID:8805640   PMID:9104814  
PMID:9109395   PMID:9162022   PMID:9168896   PMID:9326234   PMID:9435233   PMID:9461607   PMID:9507943   PMID:9535738   PMID:9552007   PMID:9568681   PMID:9744279   PMID:9915784  
PMID:10206649   PMID:10747083   PMID:10764746   PMID:10848577   PMID:10875917   PMID:10950109   PMID:11112773   PMID:11126399   PMID:11144293   PMID:11163081   PMID:11169260   PMID:11197692  
PMID:11212177   PMID:11244088   PMID:11279055   PMID:11285131   PMID:11315843   PMID:11357933   PMID:11371414   PMID:11448951   PMID:11520075   PMID:11600223   PMID:11737221   PMID:11762942  
PMID:11804591   PMID:11861282   PMID:11882518   PMID:11904678   PMID:11907088   PMID:11907583   PMID:11961180   PMID:11979305   PMID:12011375   PMID:12049175   PMID:12122509   PMID:12144133  
PMID:12161545   PMID:12209506   PMID:12209507   PMID:12217957   PMID:12220546   PMID:12233877   PMID:12296856   PMID:12351485   PMID:12353079   PMID:12364441   PMID:12370298   PMID:12371624  
PMID:12477932   PMID:12530121   PMID:12559634   PMID:12601524   PMID:12610052   PMID:12610797   PMID:12651071   PMID:12661999   PMID:12730509   PMID:12739039   PMID:12770792   PMID:12786601  
PMID:12858434   PMID:12858454   PMID:12880679   PMID:12882979   PMID:12918703   PMID:12960285   PMID:14506926   PMID:14532286   PMID:14565595   PMID:14651520   PMID:14688072   PMID:14688526  
PMID:14728878   PMID:14743216   PMID:14872483   PMID:15000697   PMID:15018649   PMID:15022314   PMID:15041705   PMID:15071724   PMID:15091317   PMID:15142217   PMID:15146559   PMID:15173183  
PMID:15212671   PMID:15252214   PMID:15274667   PMID:15301860   PMID:15355698   PMID:15457442   PMID:15459750   PMID:15485837   PMID:15489334   PMID:15526005   PMID:15555301   PMID:15572357  
PMID:15585313   PMID:15603867   PMID:15657078   PMID:15674653   PMID:15743036   PMID:15784704   PMID:15787661   PMID:15805680   PMID:15842589   PMID:15851552   PMID:15863392   PMID:15886863  
PMID:15899873   PMID:15920055   PMID:15943902   PMID:16003175   PMID:16142859   PMID:16195372   PMID:16277675   PMID:16282562   PMID:16502120   PMID:16580225   PMID:16645020   PMID:16710414  
PMID:16731080   PMID:16732050   PMID:16732051   PMID:16846840   PMID:16871413   PMID:16979382   PMID:16980123   PMID:17010968   PMID:17028114   PMID:17207711   PMID:17220297   PMID:17258924  
PMID:17267158   PMID:17331078   PMID:17346438   PMID:17530646   PMID:17634906   PMID:17703412   PMID:17763205   PMID:17785864   PMID:17825894   PMID:17852784   PMID:17998218   PMID:18029348  
PMID:18038243   PMID:18068948   PMID:18080762   PMID:18083240   PMID:18088549   PMID:18173921   PMID:18206417   PMID:18248655   PMID:18309487   PMID:18337349   PMID:18385279   PMID:18415772  
PMID:18417150   PMID:18429822   PMID:18510047   PMID:18535030   PMID:18538149   PMID:18544535   PMID:18565259   PMID:18571427   PMID:18593464   PMID:18636124   PMID:18671942   PMID:18679053  
PMID:18685868   PMID:18715339   PMID:18717726   PMID:18755894   PMID:18764880   PMID:18807256   PMID:18818748   PMID:19019335   PMID:19050632   PMID:19068596   PMID:19070941   PMID:19074885  
PMID:19084540   PMID:19141860   PMID:19174780   PMID:19177266   PMID:19193342   PMID:19212208   PMID:19238748   PMID:19246939   PMID:19258923   PMID:19262425   PMID:19287455   PMID:19336370  
PMID:19339767   PMID:19343543   PMID:19369902   PMID:19421420   PMID:19422935   PMID:19442614   PMID:19453261   PMID:19473970   PMID:19497711   PMID:19527514   PMID:19557004   PMID:19561157  
PMID:19641466   PMID:19650780   PMID:19684152   PMID:19692652   PMID:19738620   PMID:19772798   PMID:19773279   PMID:19773451   PMID:19801788   PMID:19811435   PMID:19839997   PMID:19846171  
PMID:19892918   PMID:19900796   PMID:19913121   PMID:20038584   PMID:20045350   PMID:20074459   PMID:20100586   PMID:20181891   PMID:20217072   PMID:20237496   PMID:20300049   PMID:20305143  
PMID:20369486   PMID:20371430   PMID:20395596   PMID:20401725   PMID:20430728   PMID:20452482   PMID:20485444   PMID:20488723   PMID:20503287   PMID:20516030   PMID:20548340   PMID:20556591  
PMID:20568250   PMID:20602615   PMID:20628086   PMID:20628624   PMID:20646319   PMID:20673868   PMID:20842464   PMID:20959405   PMID:20980627   PMID:21150695   PMID:21153348   PMID:21153362  
PMID:21174572   PMID:21288590   PMID:21350240   PMID:21393509   PMID:21403886   PMID:21419569   PMID:21523796   PMID:21554999   PMID:21558270   PMID:21584225   PMID:21673044   PMID:21777909  
PMID:21809341   PMID:21813066   PMID:21849023   PMID:21850048   PMID:21873635   PMID:21895688   PMID:21920667   PMID:21988832   PMID:21994466   PMID:21995493   PMID:22057614   PMID:22068019  
PMID:22110694   PMID:22215119   PMID:22221522   PMID:22228740   PMID:22342236   PMID:22451321   PMID:22461090   PMID:22480688   PMID:22525685   PMID:22547679   PMID:22573350   PMID:22617158  
PMID:22743059   PMID:22860894   PMID:22921902   PMID:23082052   PMID:23086255   PMID:23095497   PMID:23316846   PMID:23408847   PMID:23532748   PMID:23619127   PMID:23672298   PMID:23712715  
PMID:23799986   PMID:23861542   PMID:23895422   PMID:23948613   PMID:24070898   PMID:24076392   PMID:24121042   PMID:24136332   PMID:24165468   PMID:24301904   PMID:24310780   PMID:24457057  
PMID:24511129   PMID:24578190   PMID:24711449   PMID:24717758   PMID:24748490   PMID:24777778   PMID:24782596   PMID:24836084   PMID:24844917   PMID:24896334   PMID:24898299   PMID:24923671  
PMID:24966471   PMID:25010932   PMID:25034210   PMID:25039986   PMID:25061744   PMID:25086184   PMID:25098821   PMID:25113639   PMID:25152365   PMID:25229755   PMID:25275127   PMID:25288570  
PMID:25292131   PMID:25363549   PMID:25416967   PMID:25419735   PMID:25497703   PMID:25537528   PMID:25609706   PMID:25749018   PMID:25783484   PMID:25828588   PMID:25850964   PMID:25854576  
PMID:25860248   PMID:25889297   PMID:25924204   PMID:25940088   PMID:25982858   PMID:26019295   PMID:26071216   PMID:26177311   PMID:26258847   PMID:26280204   PMID:26425877   PMID:26476273  
PMID:26483205   PMID:26492598   PMID:26569118   PMID:26574625   PMID:26708145   PMID:26854079   PMID:26928194   PMID:26993379   PMID:27040725   PMID:27081759   PMID:27104820   PMID:27145290  
PMID:27158798   PMID:27270893   PMID:27528091   PMID:27560480   PMID:27626702   PMID:27640805   PMID:27791020   PMID:27973968   PMID:28096513   PMID:28150360   PMID:28159803   PMID:28215307  
PMID:28256549   PMID:28367848   PMID:28389814   PMID:28489742   PMID:28667032   PMID:28677724   PMID:28744116   PMID:28815559   PMID:28830973   PMID:29212072   PMID:29287713   PMID:29342501  
PMID:29378181   PMID:29547707   PMID:29559979   PMID:29619032   PMID:29625336   PMID:29686027   PMID:29740434   PMID:29748156   PMID:29752424   PMID:29799484   PMID:29892300   PMID:29915336  
PMID:29922294   PMID:30075559   PMID:30081046   PMID:30104686   PMID:30254506   PMID:30324895   PMID:30374604   PMID:30472484   PMID:30628200   PMID:30793619   PMID:30910714   PMID:30989732  
PMID:31153055   PMID:31207020   PMID:31494339   PMID:31559449   PMID:31734995   PMID:31840071   PMID:31872456   PMID:31875557   PMID:31906244   PMID:32073741   PMID:32083339   PMID:32202358  
PMID:32272224   PMID:32397343   PMID:32449229   PMID:32559305   PMID:32643269   PMID:32968279   PMID:32988586   PMID:33155962   PMID:33162992   PMID:33258176   PMID:33293464   PMID:33536237  
PMID:33609401   PMID:33619115   PMID:33918875   PMID:33932814   PMID:33949291   PMID:33961781   PMID:34062547   PMID:34185706   PMID:34210601   PMID:34227081   PMID:34359880   PMID:34415356  
PMID:34595982   PMID:34614352   PMID:34739338   PMID:35149531   PMID:35163403   PMID:35216240   PMID:35258553   PMID:35294530   PMID:35296554   PMID:35404389   PMID:35413081   PMID:35681430  
PMID:35746645   PMID:35874723   PMID:35979166   PMID:36012570   PMID:36185580   PMID:36611799   PMID:36865537   PMID:37589506   PMID:37600801  


Genomics

Comparative Map Data
TNFRSF1B
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38112,166,991 - 12,209,220 (+)NCBIGRCh38GRCh38hg38GRCh38
GRCh38.p14 Ensembl112,166,991 - 12,209,228 (+)EnsemblGRCh38hg38GRCh38
GRCh37112,227,048 - 12,269,277 (+)NCBIGRCh37GRCh37hg19GRCh37
Build 36112,149,647 - 12,191,864 (+)NCBINCBI36Build 36hg18NCBI36
Build 34112,161,325 - 12,203,542NCBI
Celera111,340,352 - 11,382,470 (+)NCBICelera
Cytogenetic Map1p36.22NCBI
HuRef111,380,310 - 11,422,542 (+)NCBIHuRef
CHM1_1112,214,947 - 12,257,256 (+)NCBICHM1_1
T2T-CHM13v2.0111,711,114 - 11,753,352 (+)NCBIT2T-CHM13v2.0
Tnfrsf1b
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm394144,938,938 - 144,973,453 (-)NCBIGRCm39GRCm39mm39
GRCm39 Ensembl4144,940,033 - 144,973,440 (-)EnsemblGRCm39 Ensembl
GRCm384145,212,368 - 145,246,870 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl4145,213,463 - 145,246,870 (-)EnsemblGRCm38mm10GRCm38
MGSCv374144,802,271 - 144,836,773 (-)NCBIGRCm37MGSCv37mm9NCBIm37
MGSCv364144,479,055 - 144,513,557 (-)NCBIMGSCv36mm8
Celera4146,801,795 - 146,837,140 (-)NCBICelera
Cytogenetic Map4E1NCBI
cM Map478.17NCBI
Tnfrsf1b
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.25157,070,642 - 157,104,216 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl5157,070,642 - 157,104,206 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx5159,775,748 - 159,806,642 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.05161,549,033 - 161,579,923 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.05161,505,389 - 161,536,279 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.05163,136,390 - 163,167,299 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl5163,136,390 - 163,167,299 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.05166,815,372 - 166,845,910 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.45163,666,541 - 163,697,484 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.15163,674,328 - 163,707,672 (-)NCBI
Celera5155,362,574 - 155,393,443 (-)NCBICelera
Cytogenetic Map5q36NCBI
Tnfrsf1b
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_0049554861,792,115 - 1,818,362 (-)EnsemblChiLan1.0
ChiLan1.0NW_0049554861,790,531 - 1,817,986 (-)NCBIChiLan1.0ChiLan1.0
TNFRSF1B
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
NHGRI_mPanPan11214,675,232 - 214,717,231 (-)NCBINHGRI_mPanPan1
Mhudiblu_PPA_v0110,915,743 - 10,957,765 (+)NCBIMhudiblu_PPA_v0Mhudiblu_PPA_v0panPan3
PanPan1.1112,130,663 - 12,172,646 (+)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl112,130,663 - 12,172,646 (+)Ensemblpanpan1.1panPan2
TNFRSF1B
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1284,140,179 - 84,151,219 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
CanFam3.1 Ensembl284,141,911 - 84,157,191 (-)EnsemblCanFam3.1canFam3CanFam3.1
Dog10K_Boxer_Tasha280,674,178 - 80,701,012 (-)NCBIDog10K_Boxer_Tasha
ROS_Cfam_1.0284,802,376 - 84,828,308 (-)NCBIROS_Cfam_1.0
ROS_Cfam_1.0 Ensembl284,801,328 - 84,828,324 (-)EnsemblROS_Cfam_1.0 Ensembl
UMICH_Zoey_3.1281,551,315 - 81,578,384 (-)NCBIUMICH_Zoey_3.1
UNSW_CanFamBas_1.0282,551,181 - 82,578,413 (-)NCBIUNSW_CanFamBas_1.0
UU_Cfam_GSD_1.0283,616,667 - 83,643,630 (-)NCBIUU_Cfam_GSD_1.0
Tnfrsf1b
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HiC_Itri_2NW_02440505835,083,616 - 35,110,985 (+)NCBIHiC_Itri_2
SpeTri2.0 EnsemblNW_004936474908,485 - 934,177 (+)EnsemblSpeTri2.0
SpeTri2.0NW_004936474908,414 - 935,765 (+)NCBISpeTri2.0SpeTri2.0SpeTri2.0
TNFRSF1B
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl672,195,435 - 72,231,147 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.1672,195,420 - 72,231,146 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
TNFRSF1B
(Chlorocebus sabaeus - green monkey)
Green Monkey AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChlSab1.120119,590,621 - 119,633,562 (-)NCBIChlSab1.1ChlSab1.1chlSab2
ChlSab1.1 Ensembl20119,590,325 - 119,633,497 (-)EnsemblChlSab1.1ChlSab1.1 EnsemblchlSab2
Vero_WHO_p1.0NW_02366605423,447,248 - 23,490,475 (-)NCBIVero_WHO_p1.0Vero_WHO_p1.0
Tnfrsf1b
(Heterocephalus glaber - naked mole-rat)
Naked Mole-Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla_female_1.0 EnsemblNW_004624818896,150 - 922,710 (-)EnsemblHetGla_female_1.0HetGla_female_1.0 EnsemblhetGla2
HetGla 1.0NW_004624818894,470 - 922,806 (-)NCBIHetGla_female_1.0HetGla 1.0hetGla2

Variants

.
Variants in TNFRSF1B
27 total Variants

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 1p36.22-36.21(chr1:11654070-12768656)x3 copy number gain See cases [RCV000051460] Chr1:11654070..12768656 [GRCh38]
Chr1:11714127..12828807 [GRCh37]
Chr1:11636714..12751394 [NCBI36]
Chr1:1p36.22-36.21		 uncertain significance
GRCh38/hg38 1p36.22(chr1:11737130-12169786)x3 copy number gain See cases [RCV000051461] Chr1:11737130..12169786 [GRCh38]
Chr1:11797187..12229843 [GRCh37]
Chr1:11719774..12152430 [NCBI36]
Chr1:1p36.22		 uncertain significance
GRCh38/hg38 1p36.31-36.21(chr1:6652339-12724844)x3 copy number gain See cases [RCV000051794] Chr1:6652339..12724844 [GRCh38]
Chr1:6712399..12784811 [GRCh37]
Chr1:6634986..12707398 [NCBI36]
Chr1:1p36.31-36.21		 pathogenic
GRCh38/hg38 1p36.31-36.13(chr1:6853513-17326813)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051795]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051795]|See cases [RCV000051795] Chr1:6853513..17326813 [GRCh38]
Chr1:6913573..17685411 [GRCh37]
Chr1:6836160..17557998 [NCBI36]
Chr1:1p36.31-36.13		 pathogenic
GRCh38/hg38 1p36.22-36.21(chr1:12149586-13111056)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051796]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000051796]|See cases [RCV000051796] Chr1:12149586..13111056 [GRCh38]
Chr1:12209643..13178528 [GRCh37]
Chr1:12132230..13101115 [NCBI36]
Chr1:1p36.22-36.21		 pathogenic
GRCh38/hg38 1p36.32-36.21(chr1:2963330-12666744)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053713]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053713]|See cases [RCV000053713] Chr1:2963330..12666744 [GRCh38]
Chr1:2879895..12726755 [GRCh37]
Chr1:2869755..12649342 [NCBI36]
Chr1:1p36.32-36.21		 pathogenic
GRCh38/hg38 1p36.32-36.13(chr1:3006193-17688934)x1 copy number loss See cases [RCV000053714] Chr1:3006193..17688934 [GRCh38]
Chr1:2922757..18015429 [GRCh37]
Chr1:2912617..17888016 [NCBI36]
Chr1:1p36.32-36.13		 pathogenic
GRCh38/hg38 1p36.32-36.21(chr1:4898439-13111056)x1 copy number loss See cases [RCV000053724] Chr1:4898439..13111056 [GRCh38]
Chr1:4958499..13178528 [GRCh37]
Chr1:4858359..13101115 [NCBI36]
Chr1:1p36.32-36.21		 pathogenic
GRCh38/hg38 1p36.22-36.12(chr1:10556797-22557907)x1 copy number loss See cases [RCV000053760] Chr1:10556797..22557907 [GRCh38]
Chr1:10616854..22884400 [GRCh37]
Chr1:10539441..22756987 [NCBI36]
Chr1:1p36.22-36.12		 pathogenic
GRCh38/hg38 1p36.22-36.13(chr1:10621776-16520709)x1 copy number loss See cases [RCV000053763] Chr1:10621776..16520709 [GRCh38]
Chr1:10681833..16847204 [GRCh37]
Chr1:10604420..16719791 [NCBI36]
Chr1:1p36.22-36.13		 pathogenic
GRCh38/hg38 1p36.22-36.13(chr1:10809039-16422500)x1 copy number loss See cases [RCV000053765] Chr1:10809039..16422500 [GRCh38]
Chr1:10869096..16748995 [GRCh37]
Chr1:10791683..16621582 [NCBI36]
Chr1:1p36.22-36.13		 pathogenic
GRCh38/hg38 1p36.22-36.13(chr1:11121625-16324498)x1 copy number loss See cases [RCV000053766] Chr1:11121625..16324498 [GRCh38]
Chr1:11181682..16650993 [GRCh37]
Chr1:11104269..16523580 [NCBI36]
Chr1:1p36.22-36.13		 pathogenic
GRCh38/hg38 1p36.23-36.21(chr1:7165036-13111056)x1 copy number loss See cases [RCV000053755] Chr1:7165036..13111056 [GRCh38]
Chr1:7225096..13178528 [GRCh37]
Chr1:7147683..13101115 [NCBI36]
Chr1:1p36.23-36.21		 pathogenic
GRCh38/hg38 1p36.23-36.13(chr1:9034671-16441465)x1 copy number loss See cases [RCV000053756] Chr1:9034671..16441465 [GRCh38]
Chr1:9094730..16767960 [GRCh37]
Chr1:9017317..16640547 [NCBI36]
Chr1:1p36.23-36.13		 pathogenic
GRCh38/hg38 1p36.22-36.21(chr1:9406722-12852772)x1 copy number loss Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053757]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053757]|See cases [RCV000053757] Chr1:9406722..12852772 [GRCh38]
Chr1:9466781..12912625 [GRCh37]
Chr1:9389368..12835212 [NCBI36]
Chr1:1p36.22-36.21		 pathogenic
NM_001066.2(TNFRSF1B):c.720C>T (p.Ser240=) single nucleotide variant Malignant melanoma [RCV000064056] Chr1:12193031 [GRCh38]
Chr1:12253088 [GRCh37]
Chr1:12175675 [NCBI36]
Chr1:1p36.22		 not provided
NM_001066.2(TNFRSF1B):c.1275G>A (p.Lys425=) single nucleotide variant Malignant melanoma [RCV000059855] Chr1:12206909 [GRCh38]
Chr1:12266966 [GRCh37]
Chr1:12189553 [NCBI36]
Chr1:1p36.22		 not provided
GRCh38/hg38 1p36.23-36.21(chr1:9064492-12666744)x1 copy number loss See cases [RCV000133779] Chr1:9064492..12666744 [GRCh38]
Chr1:9124551..12726755 [GRCh37]
Chr1:9047138..12649342 [NCBI36]
Chr1:1p36.23-36.21		 pathogenic
GRCh38/hg38 1p36.23-36.22(chr1:8283694-12470133)x1 copy number loss See cases [RCV000135807] Chr1:8283694..12470133 [GRCh38]
Chr1:8343754..12530188 [GRCh37]
Chr1:8266341..12452775 [NCBI36]
Chr1:1p36.23-36.22		 pathogenic
GRCh38/hg38 1p36.33-36.22(chr1:844347-12470133)x1 copy number loss See cases [RCV000136695] Chr1:844347..12470133 [GRCh38]
Chr1:779727..12530188 [GRCh37]
Chr1:769590..12452775 [NCBI36]
Chr1:1p36.33-36.22		 pathogenic|likely pathogenic
GRCh38/hg38 1p36.32-36.21(chr1:4898439-12911913)x1 copy number loss See cases [RCV000137461] Chr1:4898439..12911913 [GRCh38]
Chr1:4958499..12971757 [GRCh37]
Chr1:4858359..12894344 [NCBI36]
Chr1:1p36.32-36.21		 pathogenic
GRCh38/hg38 1p36.31-36.21(chr1:6303641-15799093)x1 copy number loss See cases [RCV000137948] Chr1:6303641..15799093 [GRCh38]
Chr1:6363701..16125588 [GRCh37]
Chr1:6286288..15998175 [NCBI36]
Chr1:1p36.31-36.21		 pathogenic|likely benign
GRCh38/hg38 1p36.22-36.21(chr1:9428538-15815791)x1 copy number loss See cases [RCV000140873] Chr1:9428538..15815791 [GRCh38]
Chr1:9488597..16142286 [GRCh37]
Chr1:9411184..16014873 [NCBI36]
Chr1:1p36.22-36.21		 pathogenic
GRCh38/hg38 1p36.22-36.21(chr1:11021751-15236671)x3 copy number gain See cases [RCV000141823] Chr1:11021751..15236671 [GRCh38]
Chr1:11081808..15563167 [GRCh37]
Chr1:11004395..15435754 [NCBI36]
Chr1:1p36.22-36.21		 likely pathogenic
GRCh38/hg38 1p36.22-36.21(chr1:10264397-15780840)x1 copy number loss See cases [RCV000141438] Chr1:10264397..15780840 [GRCh38]
Chr1:10324455..16107335 [GRCh37]
Chr1:10247042..15979922 [NCBI36]
Chr1:1p36.22-36.21		 pathogenic
GRCh38/hg38 1p36.31-36.13(chr1:6554885-16056011)x3 copy number gain See cases [RCV000142906] Chr1:6554885..16056011 [GRCh38]
Chr1:6614945..16382506 [GRCh37]
Chr1:6537532..16255093 [NCBI36]
Chr1:1p36.31-36.13		 pathogenic
GRCh38/hg38 1p36.31-36.13(chr1:5363826-18360302)x1 copy number loss See cases [RCV000142771] Chr1:5363826..18360302 [GRCh38]
Chr1:5423886..18686796 [GRCh37]
Chr1:5323746..18559383 [NCBI36]
Chr1:1p36.31-36.13		 pathogenic
Single allele complex Ductal breast carcinoma [RCV000207058] Chr1:909238..24706269 [GRCh37]
Chr1:1p36.33-36.11		 uncertain significance
chr1:909238-16736132 complex variant complex Ductal breast carcinoma [RCV000207094] Chr1:909238..16736132 [GRCh37]
Chr1:1p36.33-36.13		 uncertain significance
GRCh37/hg19 1p36.33-36.22(chr1:82154-12699337)x1 copy number loss See cases [RCV000239416] Chr1:82154..12699337 [GRCh37]
Chr1:1p36.33-36.22		 pathogenic
GRCh37/hg19 1p36.33-36.21(chr1:746608-15077159)x1 copy number loss See cases [RCV000240403] Chr1:746608..15077159 [GRCh37]
Chr1:1p36.33-36.21		 pathogenic
GRCh37/hg19 1p36.23-36.21(chr1:8255222-12785220)x3 copy number gain See cases [RCV000240284] Chr1:8255222..12785220 [GRCh37]
Chr1:1p36.23-36.21		 likely pathogenic
GRCh37/hg19 1p36.32-36.21(chr1:4558588-13187457)x1 copy number loss See cases [RCV000446359] Chr1:4558588..13187457 [GRCh37]
Chr1:1p36.32-36.21		 pathogenic
GRCh37/hg19 1p36.32-36.12(chr1:2749920-22564787)x1 copy number loss See cases [RCV000446470] Chr1:2749920..22564787 [GRCh37]
Chr1:1p36.32-36.12		 pathogenic
GRCh37/hg19 1p36.22-36.21(chr1:10722955-12910774)x1 copy number loss See cases [RCV000510444] Chr1:10722955..12910774 [GRCh37]
Chr1:1p36.22-36.21		 likely pathogenic
GRCh37/hg19 1p36.22-36.21(chr1:11143298-13709344)x3 copy number gain See cases [RCV000510407] Chr1:11143298..13709344 [GRCh37]
Chr1:1p36.22-36.21		 uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684)x3 copy number gain See cases [RCV000510383] Chr1:849467..249224684 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
GRCh37/hg19 1p36.33-q44(chr1:849467-249224684) copy number gain See cases [RCV000510926] Chr1:849467..249224684 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
GRCh37/hg19 1p36.22-36.21(chr1:10722725-14267773)x1 copy number loss See cases [RCV000512501] Chr1:10722725..14267773 [GRCh37]
Chr1:1p36.22-36.21		 likely pathogenic
GRCh37/hg19 1p36.23-36.13(chr1:8850514-16272383)x1 copy number loss See cases [RCV000512226] Chr1:8850514..16272383 [GRCh37]
Chr1:1p36.23-36.13		 likely pathogenic
GRCh37/hg19 1p36.22-21.1(chr1:103343285-103455144)x3 copy number gain Global developmental delay [RCV000787285] Chr1:103343285..103455144 [GRCh37]
Chr1:1p36.22-21.1		 uncertain significance
Single allele deletion Cerebellar dysfunction with variable cognitive and behavioral abnormalities [RCV000735904] Chr1:12030001..12898000 [GRCh37]
Chr1:1p36.22-36.21		 uncertain significance
GRCh37/hg19 1p36.33-q44(chr1:47851-249228449)x3 copy number gain not provided [RCV000736295] Chr1:47851..249228449 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
GRCh37/hg19 1p36.33-q44(chr1:82154-249218992)x3 copy number gain not provided [RCV000736305] Chr1:82154..249218992 [GRCh37]
Chr1:1p36.33-q44		 pathogenic
NM_001066.3(TNFRSF1B):c.972G>C (p.Pro324=) single nucleotide variant not provided [RCV000940391] Chr1:12202038 [GRCh38]
Chr1:12262095 [GRCh37]
Chr1:1p36.22		 likely benign
NM_001066.3(TNFRSF1B):c.768C>T (p.Gly256=) single nucleotide variant not provided [RCV000941594] Chr1:12193079 [GRCh38]
Chr1:12253136 [GRCh37]
Chr1:1p36.22		 likely benign
NM_001066.3(TNFRSF1B):c.787+7C>A single nucleotide variant not provided [RCV000905625] Chr1:12193105 [GRCh38]
Chr1:12253162 [GRCh37]
Chr1:1p36.22		 likely benign
NM_001066.3(TNFRSF1B):c.543C>T (p.Pro181=) single nucleotide variant not provided [RCV000906114] Chr1:12192516 [GRCh38]
Chr1:12252573 [GRCh37]
Chr1:1p36.22		 benign
NM_001066.3(TNFRSF1B):c.608C>T (p.Thr203Met) single nucleotide variant not provided [RCV000921021] Chr1:12192919 [GRCh38]
Chr1:12252976 [GRCh37]
Chr1:1p36.22		 benign
GRCh37/hg19 1p36.22-36.21(chr1:11794553-12786444)x3 copy number gain See cases [RCV000790593] Chr1:11794553..12786444 [GRCh37]
Chr1:1p36.22-36.21		 pathogenic
NM_001066.3(TNFRSF1B):c.919A>G (p.Lys307Glu) single nucleotide variant not provided [RCV000960816] Chr1:12201985 [GRCh38]
Chr1:12262042 [GRCh37]
Chr1:1p36.22		 benign
NM_001066.3(TNFRSF1B):c.559G>A (p.Val187Met) single nucleotide variant not provided [RCV000909957] Chr1:12192870 [GRCh38]
Chr1:12252927 [GRCh37]
Chr1:1p36.22		 benign
NM_001066.3(TNFRSF1B):c.791T>C (p.Leu264Pro) single nucleotide variant not provided [RCV000961254] Chr1:12193958 [GRCh38]
Chr1:12254015 [GRCh37]
Chr1:1p36.22		 benign
GRCh37/hg19 1p36.22-36.21(chr1:11690766-12835739) copy number loss not provided [RCV000767547] Chr1:11690766..12835739 [GRCh37]
Chr1:1p36.22-36.21		 pathogenic
GRCh37/hg19 1p36.22-36.21(chr1:10246640-12841900)x1 copy number loss not provided [RCV000846372] Chr1:10246640..12841900 [GRCh37]
Chr1:1p36.22-36.21		 uncertain significance
NM_001066.3(TNFRSF1B):c.138T>C (p.Tyr46=) single nucleotide variant not provided [RCV000913901] Chr1:12188855 [GRCh38]
Chr1:12248912 [GRCh37]
Chr1:1p36.22		 likely benign
NM_001066.3(TNFRSF1B):c.587T>G (p.Met196Arg) single nucleotide variant Susceptibility to severe coronavirus disease (COVID-19) [RCV001354054]|Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR2 [RCV001836993] Chr1:12192898 [GRCh38]
Chr1:12252955 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.*215C>T single nucleotide variant Susceptibility to severe coronavirus disease (COVID-19) [RCV001354055]|Susceptibility to severe coronavirus disease (COVID-19) due to high plasma levels of TNF, TNFR, and/or TNFR3 [RCV001836994] Chr1:12207235 [GRCh38]
Chr1:12267292 [GRCh37]
Chr1:1p36.22		 uncertain significance
GRCh37/hg19 1p36.33-36.13(chr1:849466-17525065)x1 copy number loss not provided [RCV001832902] Chr1:849466..17525065 [GRCh37]
Chr1:1p36.33-36.13		 pathogenic
NC_000001.10:g.(?_8616514)_(12476900_?)dup duplication Immunodeficiency 14 [RCV001920571] Chr1:8616514..12476900 [GRCh37]
Chr1:1p36.23-36.22		 uncertain significance
NC_000001.10:g.(?_11850737)_(12569078_?)dup duplication not provided [RCV001877528] Chr1:11850737..12569078 [GRCh37]
Chr1:1p36.22		 uncertain significance
NC_000001.10:g.(?_6485016)_(12569078_?)del deletion not provided [RCV001940096] Chr1:6485016..12569078 [GRCh37]
Chr1:1p36.31-36.22		 uncertain significance
NC_000001.10:g.(?_9304994)_(12569078_?)dup duplication Charcot-Marie-Tooth disease type 2 [RCV003119499] Chr1:9304994..12569078 [GRCh37]
Chr1:1p36.22		 uncertain significance
NC_000001.11:g.10115497_16283149dup duplication not specified [RCV002286386] Chr1:10115497..16283149 [GRCh38]
Chr1:1p36.22-36.13		 likely pathogenic
GRCh37/hg19 1p36.31-36.13(chr1:6758933-19287770)x1 copy number loss not provided [RCV002474779] Chr1:6758933..19287770 [GRCh37]
Chr1:1p36.31-36.13		 pathogenic
GRCh37/hg19 1p36.33-36.22(chr1:849467-12448956)x1 copy number loss not provided [RCV002473951] Chr1:849467..12448956 [GRCh37]
Chr1:1p36.33-36.22		 pathogenic
NM_001066.3(TNFRSF1B):c.1283G>A (p.Cys428Tyr) single nucleotide variant Inborn genetic diseases [RCV002883118] Chr1:12206917 [GRCh38]
Chr1:12266974 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.1084C>T (p.Arg362Trp) single nucleotide variant Inborn genetic diseases [RCV002660914] Chr1:12202150 [GRCh38]
Chr1:12262207 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.497C>T (p.Pro166Leu) single nucleotide variant Inborn genetic diseases [RCV002759324] Chr1:12192470 [GRCh38]
Chr1:12252527 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.497C>G (p.Pro166Arg) single nucleotide variant Inborn genetic diseases [RCV002783436] Chr1:12192470 [GRCh38]
Chr1:12252527 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.698C>A (p.Pro233His) single nucleotide variant Inborn genetic diseases [RCV002787196] Chr1:12193009 [GRCh38]
Chr1:12253066 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.1303G>A (p.Glu435Lys) single nucleotide variant Inborn genetic diseases [RCV002825799] Chr1:12206937 [GRCh38]
Chr1:12266994 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.602C>G (p.Thr201Arg) single nucleotide variant Inborn genetic diseases [RCV002813731] Chr1:12192913 [GRCh38]
Chr1:12252970 [GRCh37]
Chr1:1p36.22		 uncertain significance
NM_001066.3(TNFRSF1B):c.1041G>C (p.Gln347His) single nucleotide variant Inborn genetic diseases [RCV002897631] Chr1:12202107 [GRCh38]
Chr1:12262164 [GRCh37]
Chr1:1p36.22		 uncertain significance
NC_000001.10:g.4481271_20530242del deletion Chromosome 1p36 deletion syndrome [RCV003159574] Chr1:4481271..20530242 [GRCh37]
Chr1:1p36.32-36.12		 pathogenic
NM_001066.3(TNFRSF1B):c.925C>T (p.Arg309Trp) single nucleotide variant Inborn genetic diseases [RCV003349200] Chr1:12201991 [GRCh38]
Chr1:12262048 [GRCh37]
Chr1:1p36.22		 uncertain significance
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:1975
Count of miRNA genes:910
Interacting mature miRNAs:1078
Transcripts:ENST00000376259, ENST00000489921, ENST00000492361, ENST00000536782
Prediction methods:Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.

Markers in Region
RH63769  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,267,173 - 12,267,364UniSTSGRCh37
Build 36112,189,760 - 12,189,951RGDNCBI36
Celera111,380,366 - 11,380,557RGD
Cytogenetic Map1p36.22UniSTS
HuRef111,420,437 - 11,420,628UniSTS
GeneMap99-GB4 RH Map151.31UniSTS
GDB:315093  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,264,771 - 12,264,920UniSTSGRCh37
Build 36112,187,358 - 12,187,507RGDNCBI36
Celera111,377,964 - 11,378,113RGD
Cytogenetic Map1p36.22UniSTS
HuRef111,418,035 - 11,418,184UniSTS
SHGC-31494  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,267,163 - 12,267,363UniSTSGRCh37
Build 36112,189,750 - 12,189,950RGDNCBI36
Celera111,380,356 - 11,380,556RGD
Cytogenetic Map1p36.22UniSTS
HuRef111,420,427 - 11,420,627UniSTS
Stanford-G3 RH Map1624.0UniSTS
GeneMap99-GB4 RH Map151.31UniSTS
Whitehead-RH Map150.0UniSTS
NCBI RH Map183.5UniSTS
GeneMap99-G3 RH Map1624.0UniSTS
G15915  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37112,267,349 - 12,267,555UniSTSGRCh37
Build 36112,189,936 - 12,190,142RGDNCBI36
Celera111,380,542 - 11,380,748RGD
Cytogenetic Map1p36.22UniSTS
HuRef111,420,613 - 11,420,819UniSTS


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system visual system adipose tissue appendage entire extraembryonic component pharyngeal arch
High 88 88 1
Medium 2306 2529 1519 514 1776 393 3301 1501 1545 260 952 1411 129 1 1204 2160 5 2
Low 113 374 198 106 51 65 1040 675 2155 145 473 124 44 628 1
Below cutoff 15 8 3 25 6 12 18 30 10 30 64 1

Sequence

Nucleotide Sequences
RefSeq Transcripts NG_029791 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  NM_001066 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_011542060 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_011542063 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017002211 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017002214 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_017002215 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047429422 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047429423 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_047429424 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054338566 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054338567 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054338568 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  XM_054338569 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
GenBank Nucleotide AB030949 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AB030950 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AB030951 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AB030952 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AH006638 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AL031276 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AL357835 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AY148473 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AY264804 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  AY342040 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC011844 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC042167 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BC052977 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  BT019927 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CH471130 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CP068277 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  CS068584 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  EU826615 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  GN344135 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  HI179124 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  JA362586 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC726346 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC726347 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC726348 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC726349 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC726350 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  LC726351 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M32315 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M35857 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  M55994 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  S63368 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  U53483 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles
  X80021 (Get FASTA)   NCBI Sequence Viewer   Search GEO for Microarray Profiles

Reference Sequences
RefSeq Acc Id: ENST00000376259   ⟹   ENSP00000365435
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,166,991 - 12,209,220 (+)Ensembl
RefSeq Acc Id: ENST00000489921
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,191,838 - 12,193,008 (+)Ensembl
RefSeq Acc Id: ENST00000492361
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,167,003 - 12,209,228 (+)Ensembl
RefSeq Acc Id: ENST00000536782   ⟹   ENSP00000440425
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p14 Ensembl112,167,003 - 12,192,358 (+)Ensembl
RefSeq Acc Id: NM_001066   ⟹   NP_001057
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,166,991 - 12,209,220 (+)NCBI
GRCh37112,227,044 - 12,269,279 (+)NCBI
Build 36112,149,647 - 12,191,864 (+)NCBI Archive
HuRef111,380,310 - 11,422,542 (+)ENTREZGENE
CHM1_1112,214,947 - 12,257,256 (+)NCBI
T2T-CHM13v2.0111,711,114 - 11,753,352 (+)NCBI
Sequence:
RefSeq Acc Id: XM_011542060   ⟹   XP_011540362
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,166,991 - 12,209,220 (+)NCBI
Sequence:
RefSeq Acc Id: XM_011542063   ⟹   XP_011540365
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,166,991 - 12,209,220 (+)NCBI
Sequence:
RefSeq Acc Id: XM_047429422   ⟹   XP_047285378
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,166,991 - 12,209,220 (+)NCBI
RefSeq Acc Id: XM_047429423   ⟹   XP_047285379
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,187,439 - 12,209,220 (+)NCBI
RefSeq Acc Id: XM_047429424   ⟹   XP_047285380
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,184,528 - 12,209,220 (+)NCBI
RefSeq Acc Id: XM_054338566   ⟹   XP_054194541
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0111,711,114 - 11,753,352 (+)NCBI
RefSeq Acc Id: XM_054338567   ⟹   XP_054194542
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0111,711,114 - 11,753,352 (+)NCBI
RefSeq Acc Id: XM_054338568   ⟹   XP_054194543
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0111,731,568 - 11,753,352 (+)NCBI
RefSeq Acc Id: XM_054338569   ⟹   XP_054194544
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
T2T-CHM13v2.0111,711,114 - 11,753,352 (+)NCBI
Protein Sequences
Protein RefSeqs NP_001057 (Get FASTA)   NCBI Sequence Viewer  
  XP_011540362 (Get FASTA)   NCBI Sequence Viewer  
  XP_011540365 (Get FASTA)   NCBI Sequence Viewer  
  XP_047285378 (Get FASTA)   NCBI Sequence Viewer  
  XP_047285379 (Get FASTA)   NCBI Sequence Viewer  
  XP_047285380 (Get FASTA)   NCBI Sequence Viewer  
  XP_054194541 (Get FASTA)   NCBI Sequence Viewer  
  XP_054194542 (Get FASTA)   NCBI Sequence Viewer  
  XP_054194543 (Get FASTA)   NCBI Sequence Viewer  
  XP_054194544 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAA36755 (Get FASTA)   NCBI Sequence Viewer  
  AAA59929 (Get FASTA)   NCBI Sequence Viewer  
  AAA63262 (Get FASTA)   NCBI Sequence Viewer  
  AAB19824 (Get FASTA)   NCBI Sequence Viewer  
  AAC50622 (Get FASTA)   NCBI Sequence Viewer  
  AAD14848 (Get FASTA)   NCBI Sequence Viewer  
  AAH11844 (Get FASTA)   NCBI Sequence Viewer  
  AAH42167 (Get FASTA)   NCBI Sequence Viewer  
  AAH52977 (Get FASTA)   NCBI Sequence Viewer  
  AAN72434 (Get FASTA)   NCBI Sequence Viewer  
  AAO89076 (Get FASTA)   NCBI Sequence Viewer  
  AAP88939 (Get FASTA)   NCBI Sequence Viewer  
  AAV38730 (Get FASTA)   NCBI Sequence Viewer  
  ACF47651 (Get FASTA)   NCBI Sequence Viewer  
  BAA89052 (Get FASTA)   NCBI Sequence Viewer  
  BAA89053 (Get FASTA)   NCBI Sequence Viewer  
  BAA89054 (Get FASTA)   NCBI Sequence Viewer  
  BAA89055 (Get FASTA)   NCBI Sequence Viewer  
  CAA56324 (Get FASTA)   NCBI Sequence Viewer  
  CAI84623 (Get FASTA)   NCBI Sequence Viewer  
  CAY56003 (Get FASTA)   NCBI Sequence Viewer  
  CBX53870 (Get FASTA)   NCBI Sequence Viewer  
  CCA94575 (Get FASTA)   NCBI Sequence Viewer  
  EAW71731 (Get FASTA)   NCBI Sequence Viewer  
  EAW71732 (Get FASTA)   NCBI Sequence Viewer  
  EAW71733 (Get FASTA)   NCBI Sequence Viewer  
  EAW71734 (Get FASTA)   NCBI Sequence Viewer  
  EAW71735 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSP00000365435
  ENSP00000365435.3
  ENSP00000440425.1
GenBank Protein P20333 (Get FASTA)   NCBI Sequence Viewer  
Reference Protein Sequences
RefSeq Acc Id: NP_001057   ⟸   NM_001066
- Peptide Label: precursor
- UniProtKB: Q6YI29 (UniProtKB/Swiss-Prot),   Q16042 (UniProtKB/Swiss-Prot),   B1AJZ3 (UniProtKB/Swiss-Prot),   Q9UIH1 (UniProtKB/Swiss-Prot),   P20333 (UniProtKB/Swiss-Prot),   Q8IVS6 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_011540362   ⟸   XM_011542060
- Peptide Label: isoform X1
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_011540365   ⟸   XM_011542063
- Peptide Label: isoform X4
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSP00000365435   ⟸   ENST00000376259
RefSeq Acc Id: ENSP00000440425   ⟸   ENST00000536782
RefSeq Acc Id: XP_047285378   ⟸   XM_047429422
- Peptide Label: isoform X2
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_047285380   ⟸   XM_047429424
- Peptide Label: isoform X5
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_047285379   ⟸   XM_047429423
- Peptide Label: isoform X3
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_054194541   ⟸   XM_054338566
- Peptide Label: isoform X1
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_054194542   ⟸   XM_054338567
- Peptide Label: isoform X2
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_054194544   ⟸   XM_054338569
- Peptide Label: isoform X4
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
RefSeq Acc Id: XP_054194543   ⟸   XM_054338568
- Peptide Label: isoform X3
- UniProtKB: Q8IVS6 (UniProtKB/TrEMBL)
Protein Domains
TNFR-Cys

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P20333-F1-model_v2 AlphaFold P20333 1-461 view protein structure

Promoters
RGD ID:6787038
Promoter ID:HG_KWN:734
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   CD4+TCell_2Hour,   K562,   Lymphoblastoid
Transcripts:ENST00000400863,   OTTHUMT00000005133,   OTTHUMT00000005134,   UC009VNK.1
Position:
Human AssemblyChrPosition (strand)Source
Build 36112,149,469 - 12,149,969 (+)MPROMDB
RGD ID:6854142
Promoter ID:EPDNEW_H236
Type:initiation region
Name:TNFRSF1B_1
Description:TNF receptor superfamily member 1B
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.; Paired-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38112,166,991 - 12,167,051EPDNEW
RGD ID:6787036
Promoter ID:HG_KWN:735
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell
Transcripts:OTTHUMT00000005135
Position:
Human AssemblyChrPosition (strand)Source
Build 36112,174,171 - 12,174,671 (+)MPROMDB

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:11917 AgrOrtholog
COSMIC TNFRSF1B COSMIC
Ensembl Genes ENSG00000028137 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENST00000376259 ENTREZGENE
  ENST00000376259.7 UniProtKB/Swiss-Prot
  ENST00000536782.2 UniProtKB/TrEMBL
Gene3D-CATH Tumor Necrosis Factor Receptor, subunit A, domain 2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
GTEx ENSG00000028137 GTEx
HGNC ID HGNC:11917 ENTREZGENE
Human Proteome Map TNFRSF1B Human Proteome Map
InterPro TNFR/NGFR_Cys_rich_reg UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  TNFR_1B UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  TNFRSF1B_N UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:7133 UniProtKB/Swiss-Prot
NCBI Gene 7133 ENTREZGENE
OMIM 191191 OMIM
PANTHER TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B UniProtKB/Swiss-Prot
  TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B UniProtKB/Swiss-Prot
  TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B UniProtKB/TrEMBL
  TUMOR NECROSIS FACTOR RECEPTOR SUPERFAMILY MEMBER 1B UniProtKB/TrEMBL
Pfam TNFR_c6 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA36610 PharmGKB, RGD
PRINTS TNFACTORR1B UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PROSITE TNFR_NGFR_1 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  TNFR_NGFR_2 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
SMART TNFR UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Superfamily-SCOP TNF receptor-like UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt A0A0K1RN68_HUMAN UniProtKB/TrEMBL
  B1AJZ3 ENTREZGENE
  B5A977_HUMAN UniProtKB/TrEMBL
  P20333 ENTREZGENE
  Q16042 ENTREZGENE
  Q6YI29 ENTREZGENE
  Q8IVS6 ENTREZGENE, UniProtKB/TrEMBL
  Q9UIH1 ENTREZGENE
  TNR1B_HUMAN UniProtKB/Swiss-Prot
UniProt Secondary B1AJZ3 UniProtKB/Swiss-Prot
  Q16042 UniProtKB/Swiss-Prot
  Q6YI29 UniProtKB/Swiss-Prot
  Q9UIH1 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2016-06-30 TNFRSF1B  TNF receptor superfamily member 1B  TNFRSF1B  tumor necrosis factor receptor superfamily member 1B  Symbol and/or name change 5135510 APPROVED
2015-11-24 TNFRSF1B  tumor necrosis factor receptor superfamily member 1B  TNFRSF1B  tumor necrosis factor receptor superfamily, member 1B  Symbol and/or name change 5135510 APPROVED